scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1044617320 |
P356 | DOI | 10.1038/MODPATHOL.2012.51 |
P8608 | Fatcat ID | release_fr35yshmdjebfflp2eca37ryia |
P932 | PMC publication ID | 3589982 |
P698 | PubMed publication ID | 22460812 |
P5875 | ResearchGate publication ID | 223989586 |
P50 | author | Benjamin A Rybicki | Q87885745 |
Dhananjay A Chitale | Q90835867 | ||
Andrew G. Rundle | Q51860952 | ||
P2093 | author name string | Deliang Tang | |
Michelle Jankowski | |||
Sheri Trudeau | |||
Oleksandr N Kryvenko | |||
P2860 | cites work | Is high grade prostatic intraepithelial neoplasia still a risk factor for adenocarcinoma in the era of extended biopsy sampling? | Q84148985 |
Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy | Q84509625 | ||
Consensus development of a histopathological classification system for chronic prostatic inflammation | Q34285913 | ||
High-grade prostatic intraepithelial neoplasia | Q34291962 | ||
Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy | Q34328872 | ||
Evidence for field cancerization of the prostate | Q34982560 | ||
Prostate carcinogenesis and inflammation: emerging insights. | Q35925066 | ||
Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. | Q36099774 | ||
Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care | Q36392405 | ||
Inflammation in prostate carcinogenesis | Q36554784 | ||
Inflammation, atrophy, and prostate carcinogenesis | Q36934776 | ||
Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies | Q39371352 | ||
Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density | Q39534420 | ||
Ki-67 expression in early prostate cancer and associated pathological lesions | Q39595976 | ||
Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study. | Q39754813 | ||
Multifocal High Grade Prostatic Intraepithelial Neoplasia is a Risk Factor for Subsequent Prostate Cancer | Q39837093 | ||
Atrophy and proliferation in the young adult prostate. | Q41248167 | ||
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis | Q41899984 | ||
Normal histology of the prostate. | Q42489226 | ||
Architectural patterns of high-grade prostatic intraepithelial neoplasia | Q42510562 | ||
Inflammatory atrophy of the prostate. Prevalence and significance | Q44322571 | ||
High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases | Q46182115 | ||
The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. | Q53343244 | ||
Repeat biopsy in patients with initial diagnosis of PIN | Q56999507 | ||
A Working Group Classification of Focal Prostate Atrophy Lesions | Q57693492 | ||
What Information are Urologists Extracting from Prostate Needle Biopsy Reports and What do They Need for Clinical Management of Prostate Cancer? | Q57693574 | ||
Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma | Q58323969 | ||
Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years? | Q63966345 | ||
Intraductal dysplasia: a premalignant lesion of the prostate | Q69995965 | ||
Mitotic activity of prostatic epithelium. A study by means of Colcemid | Q70091502 | ||
International consultation on prostatic intraepithelial neoplasia and pathologic staging of prostatic carcinoma. Rochester, Minnesota, November 3-4, 1995 | Q71170214 | ||
Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia | Q73164189 | ||
Histology and cellular kinetics of prostatic atrophy | Q77298251 | ||
Different types of atrophy in the prostate with and without adenocarcinoma | Q79849340 | ||
Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma | Q80165789 | ||
Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL | Q82173884 | ||
Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate | Q84025405 | ||
Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma | Q84067818 | ||
P433 | issue | 7 | |
P304 | page(s) | 1023-1032 | |
P577 | publication date | 2012-03-30 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer | |
P478 | volume | 25 |
Q36909164 | 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer |
Q91943707 | A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy |
Q36569963 | A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer |
Q44645667 | Active surveillance: does serial prostate biopsy increase histological inflammation? |
Q38170026 | Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study |
Q37310041 | Better cancer biomarker discovery through better study design |
Q44130971 | Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE study |
Q92358678 | Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis |
Q36499803 | Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans |
Q39296522 | Evolution of Premalignant Disease. |
Q38222638 | Evolutionary mechanism unifies the hallmarks of cancer |
Q41888259 | Genetic Variations in Inflammatory Response Genes and Their Association with the Risk of Prostate Cancer |
Q52579829 | Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial. |
Q40967154 | Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study |
Q40072464 | Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score |
Q38383521 | Inflammation and prostate cancer: friends or foe? |
Q42476253 | Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate |
Q55379481 | Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt. |
Q40920100 | Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer |
Q37187963 | Methylation of the RARB gene increases prostate cancer risk in black Americans |
Q36968554 | Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate |
Q42419357 | Polymorphisms in NFKB1 and NFKBIA Genes Modulate the Risk of Developing Prostate Cancer among Han Chinese |
Q50733820 | Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution. |
Q36896695 | Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer |
Q37105390 | Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template Biopsy. |
Q36132629 | Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. |
Q33732986 | Revisiting the hallmarks of cancer |
Q38207592 | Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer. |
Q38795318 | Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial |
Q55711410 | The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo. |
Q36643476 | Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients |
Search more.